Advisory: Alerts incorrectly tagged to T Rowe Price Large-Cap Value Fund withdrawn
22/05/2025 11:29
Alerts on Instil Bio TIL.O and ImmuneOnco Biopharmaceuticals 1541.HK announcing clinical trial updates for Phase 2 trial of ‘2510 were inadvertently tagged to T Rowe Price Large-Cap Value Fund TILCX.O, an unrelated company and have been withdrawn. For the correct set of alerts, click nFWN3RU044 STORY_NUMBER: nFWN3RU0PH STORY_DATE: 22/05/2025 STORY_TIME: 10:01:01 GMT ((Bangalore.newsroom@thomsonreuters.com))
Recent news on Instil Bio
See all newsInstil Bio, Inc. reports results for the quarter ended June 30 - Earnings Summary
Instil Bio Q2 net loss narrows on lower R&D spending, restructuring charges
Brief: Instil Bio Q2 Basic EPS USD -0.63
Instil Bio, Inc. expected to post a loss of 43 cents a share - Earnings Preview
Instil Bio Q1 net loss narrows on lower R&D expenses